In contrast, resistance to 1, 3-Bis (2-chloroethyl)-1-nitrosourea (BCNU), an alkylating agent commonly used for glioblastoma, was associated with the reduced expression of LCN2 in glioblastoma cells [44]. This evidence concerns the gene LCN2 and glioblastoma.